In recent years, the pharmaceutical business has faced unprecedented challenges. The previous three years have seen a 24% increase in the average cost of pharmaceuticals in the United States due to safety concerns, issues with specific prescriptions, and competition from both non-generic and generic medications. Prescription costs for those with private insurance decreased by 4% as a result between 2010 and 2013.Developing nations like China, India, and Brazil have comparable difficulties. Creating a series of vaccines with medicinal qualities is one such intervention.In order to treat bacter